Français
ItalianoBond AbbVie 5.2% ( US00287YEA38 ) in USD
| Issuer | AbbVie | ||||||||||||||
| Market price |  102.567 % ▼ |
||||||||||||||
| Country |  United States
|
||||||||||||||
| ISIN code |
 US00287YEA38 ( in USD )
|
||||||||||||||
| Interest rate | 5.2% per year ( payment 2 times a year) | ||||||||||||||
| Maturity | 03/15/2035 | ||||||||||||||
| Minimal amount | / | ||||||||||||||
| Total amount | / | ||||||||||||||
| Cusip | 00287YEA3 | ||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||||||||
| Next Coupon | 03/15/2027 ( In 127 days ) | ||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEA38, pays a coupon of 5.2% per year. The coupons are paid 2 times per year and the Bond maturity is 03/15/2035 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEA38, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEA38, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||
| |||||||||||||||